Assessment of hepatic prostaglandin E2 level in carbamazepine induced liver injury
By:
References
- Bertilsson L, Tomson T. Clinical pharmacokinetics and pharmacological effects of carbamazepine and carbamaze-pine-10,11-epoxide. An update. Clin Pharmacokinet 11, 177–198, 1986.10.2165/00003088-198611030-000013524954
- Bjornsson E. Hepatotoxicity associated with antiepileptic drugs. Acta Neurol Scand 118, 281–290, 2008.10.1111/j.1600-0404.2008.01009.x18341684
- Casado M, Molla B, Roy R, Fernandez-Martinez A, Cucarella C, Mayoral R, Bosca L, Martin-Sanz P. Protection against Fas-induced liver apoptosis in transgenic mice expressing cyclooxygenase 2 in hepatocytes. Hepatology 45, 631–638, 2007.10.1002/hep.2155617326157
- Cavar I, Kelava T, Vukojevic K, Saraga-Babic M, Culo F. The role of prostaglandin E2 in acute acetaminophen hepatotoxicity in mice. Histol Histopathol 25, 819–830, 2010.
- Dawson W, Jessup SJ, McDonald-Gibson W, Ramwell PW, Shaw JE. Prostaglandin uptake and metabolism by the perfused rat liver. Br J Pharmacol 39, 585–598, 1970.10.1111/j.1476-5381.1970.tb10366.x17026175472205
- Ekor M, Odewabi AO, Kale OE, Adesanoye OA, Bamidele TO. Celecoxib, a selective cyclooxygenase-2 inhibitor, lowers plasma cholesterol and attenuates hepatic lipid peroxidation during carbon-tetrachloride-associated hepatotoxicity in rats. Drug Chem Toxicol 36, 1–8, 2013.10.3109/01480545.2011.64238022168377
- Ghelardoni S, Tomita YA, Bell JM, Rapoport SI, Bosetti F. Chronic carbamazepine selectively downregulates cytosolic phospholipase A2 expression and cyclooxygenase activity in rat brain. Biol Psychiatry 56, 248–254, 2004.10.1016/j.biopsych.2004.05.01215312812
- Gose T, Nakanishi T, Kamo S, Shimada H, Otake K, Tamai I. Prostaglandin transporter (OATP2A1/SLCO2A1) contributes to local disposition of eicosapentaenoic acid-derived PGE3. Prostaglandins Other Lipid Mediat 122, 10–17, 2016.10.1016/j.prostaglandins.2015.12.00326692285
- Higuchi S, Yano A, Takai S, Tsuneyama K, Fukami T, Nakajima M, Yokoi T. Metabolic activation and inflammation reactions involved in carbamazepine-induced liver injury. Toxicol Sci 130, 4–16, 2012.10.1093/toxsci/kfs22222790970
- Hughes D, Otani T, Yang P, Newman RA, Yantiss RK, Altorki NK, Port JL, Yan M, Markowitz SD, Mazumdar M, Tai HH, Subbaramaiah K, Dannenberg AJ. NAD+-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancer. Cancer Prev Res (Phila) 1, 241–249, 2008.10.1158/1940-6207.CAPR-08-0055272056919138967
- Iida A, Sasaki E, Yano A, Tsuneyama K, Fukami T, Nakajima M, Yokoi T. Carbamazepine-induced liver injury requires CYP3A-mediated metabolism and glutathione depletion in rats. Drug Metab Dispos 43, 958–968, 2015.10.1124/dmd.115.06337025870103
- Ivanov AI, Scheck AC, Romanovsky AA. Expression of genes controlling transport and catabolism of prostaglandin E2 in lipopolysaccharide fever. Am J Physiol Regul Integr Comp Physiol 284, R698–R706, 2003.10.1152/ajpregu.00570.2002
- Kasai T, Nakanishi T, Ohno Y, Shimada H, Nakamura Y, Arakawa H, Tamai I. Role of OATP2A1 in PGE(2) secretion from human colorectal cancer cells via exocytosis in response to oxidative stress. Exp Cell Res 341, 123–131, 2016.10.1016/j.yexcr.2016.02.002
- Kuzumoto Y, Sho M, Ikeda N, Hamada K, Mizuno T, Akashi S, Tsurui Y, Kashizuka H, Nomi T, Kubo A, Kanehiro H, Nakajima Y. Significance and therapeutic potential of prostaglandin E2 receptor in hepatic ischemia/reperfusion injury in mice. Hepatology 42, 608–617, 2005.10.1002/hep.20827
- Lertratanangkoon K, Horning MG. Metabolism of carbamazepine. Drug Metab Dispos 10, 1–10, 1982.
- Lu W, Uetrecht JP. Peroxidase-mediated bioactivation of hydroxylated metabolites of carbamazepine and phenytoin. Drug Metab Dispos 36, 1624–1636, 2008.10.1124/dmd.107.019554
- Matsuo M, Ensor CM, Tai HH. Cloning and expression of the cDNA for mouse NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase. Biochim Biophys Acta 1309, 21–24, 1996.10.1016/S0167-4781(96)00123-6
- Nakamura Y, Nakanishi T, Shimada H, Shimizu J, Aotani R, Maruyama S, Higuchi K, Okura T, Deguchi Y, Tamai I. Prostaglandin transporter OATP2A1/SLCO2A1 is essential for body temperature regulation during fever. J Neurosci 38, 5584–5595, 2018.10.1523/JNEUROSCI.3276-17.2018817413129899035
- Nakanishi T, Hasegawa Y, Mimura R, Wakayama T, Uetoko Y, Komori H, Akanuma S, Hosoya K, Tamai I. Pros-taglandin transporter (PGT/SLCO2A1) protects the lung from bleomycin-induced fibrosis. PLoS One 0, e0123895, 2015.10.1371/journal.pone.0123895441448625923111
- Nakanishi T, Ohno Y, Aotani R, Maruyama S, Shimada H, Kamo S, Oshima H, Oshima M, Schuetz JD, Tamai I. A novel role for OATP2A1/SLCO2A1 in a murine model of colon cancer. Sci Rep 7, 16567, 2017.10.1038/s41598-017-16738-y570739429185482
- Nassar A, Sharon-Granit Y, Azab AN. Psychotropic drugs attenuate lipopolysaccharide-induced hypothermia by altering hypothalamic levels of inflammatory mediators in rats. Neurosci Lett 626, 59–67, 2016.10.1016/j.neulet.2016.05.01927181513
- Nishizawa N, Ito Y, Eshima K, Ohkubo H, Kojo Ken, Inoue T, Raouf J, Jakobsson PJ, Uematsu S, Akira S, Narumiya S, Waranabe M, Majima M. Inhibition of microsomal prostaglandin E synthase-1 facilitates liver repair after hepatic injury in mice. J Hepatol 69, 110–120, 2018.10.1016/j.jhep.2018.02.00929458169
- Pirmohamed M, Kitteringham NR, Breckenridge AM, Park BK. Detection of an autoantibody directed against human liver microsomal protein in a patient with carbamazepine hypersensitivity. Br J Clin Pharmacol 33, 183–186, 1992a.10.1111/j.1365-2125.1992.tb04022.x
- Pirmohamed M, Kitteringham NR, Guenthner TM, Breckenridge AM, Park BK. An investigation of the formation of cytotoxic, protein-reactive and stable metabolites from carbamazepine in vitro. Biochem Pharmacol 43, 1675–1682, 1992b.10.1016/0006-2952(92)90696-G
- Reilly TP, Brady JN, Marchick MR, Bourdi M, George JW, Radonovich MF, Pise-Masison CA, Pohl LR. A protective role for cyclooxygenase-2 in drug-induced liver injury in mice. Chem Res Toxicol 14, 1620–1628, 2001.10.1021/tx0155505
- Shimada H, Nakamura Y, Nakanishi T, Tamai I. OATP2A1/SLCO2A1-mediated prostaglandin E2 loading into intracellular acidic compartments of macrophages contributes to exocytotic secretion. Biochem Pharmacol 98, 629–638, 2015.10.1016/j.bcp.2015.10.009
- Shimada H, Hashimoto R, Aoki A, Yamada S, Oba K, Kawase A, Nakanishi T, Iwaki M. The regulatory mechanism involved in the prostaglandin E2 disposition in carbon tetrachloride-induced liver injury. Prostaglandins Leukot Essent Fatty Acids 155, 102081, 2020.10.1016/j.plefa.2020.102081
- Thiel A, Ganesan A, Mrena J, Junnila S, Nykanen A, HemmesA, Tai HH, Monni O, Kokkola A, Haglund C, Petrova TV, Ristimaki A. 15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer. Clin Cancer Res 15, 4572–4580, 2009.10.1158/1078-0432.CCR-08-2518
- Tsujii H, Okamoto Y, Kikuchi E, Matsumoto M, Nakano H. Prostaglandin E2 and rat liver regeneration. Gastroenterology 105, 495–499, 1993.10.1016/0016-5085(93)90725-R
- Xiao J, Liong EC, Huang H, Tse WO, Lau KS, Pan J, Nanji AA, Fung ML, Xing F, Tipoe GL. Cyclooxygenase-1 serves a vital hepato-protective function in chemically induced acute liver injury. Toxicol Sci 143, 430–440, 2015.10.1093/toxsci/kfu24425432964
- Zhang Y, Desai A, Yang SY, et al. TISSUE REGENERATION. Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration. Science 348, aaa2340, 2015.10.1126/science.aaa2340448112626068857
- Zidar N, Odar K, Glavac D, Jerse M, Zupanc T, Stajer D. Cyclooxygenase in normal human tissues is COX-1 really a constitutive isoform, and COX-2 an inducible isoform? J Cell Mol Med 13, 3753–3763, 2009.10.1111/j.1582-4934.2008.00430.x451652418657230
Language: English
Page range: 22 - 30
Published on: Feb 18, 2022
Published by: Slovak Academy of Sciences, Mathematical Institute
In partnership with: Paradigm Publishing Services
Publication frequency: 1 times per year
Keywords:
Related subjects:
© 2022 Ken-ichi Oba, Hiroaki Shimada, Ryota Hashimoto, Atsushi Kawase, Takeo Nakanishi, Masahiro Iwaki, published by Slovak Academy of Sciences, Mathematical Institute
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.